Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing (Q38073092)

28 August 2017

1 reference

title

Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing (English)

1 reference

28 August 2017

1 reference

mesenchymal stem cell

1 reference

3

Michael A Matthay

1 reference

28 August 2017

Rebecca L Toonkel

1

1 reference

28 August 2017

Joshua M Hare

series ordinal

2

1 reference

28 August 2017

Marilyn K Glassberg

series ordinal

4

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

American Journal of Respiratory and Critical Care Medicine

28 August 2017

1 reference

28 August 2017

188

1 reference

28 August 2017

2

1 reference

28 August 2017

133-140

1 reference

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

28 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Usual interstitial pneumonia: histologic correlation with high-resolution CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Next-generation regeneration: the hope and hype of lung stem cell research

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Therapeutic potential of mesenchymal stem cells for severe acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Use of human mesenchymal stem cells as alternative source of smooth muscle cells in vessel engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Mesenchymal stem cells: biology and potential clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Engraftment of bone marrow progenitor cells in a rat model of asbestos-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Radiation fibrosis--current clinical and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Bone marrow-derived mesenchymal stem cells in repair of the injured lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Pluripotency of mesenchymal stem cells derived from adult marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Evidence that bone marrow cells do not contribute to the alveolar epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Failure of bone marrow to reconstitute lung epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Adult cardiac stem cells are multipotent and support myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Division and differentiation of isolated CNS blast cells in microculture

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Identification of a coronary vascular progenitor cell in the human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Mesenchymal stem cells for cardiac regeneration: translation to bedside reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Identification of bronchioalveolar stem cells in normal lung and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Evidence for human lung stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Regenerative pulmonary medicine: potential and promise, pitfalls and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Pulmonary fibrosis: searching for model answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Escape from the matrix: multiple mechanisms for fibroblast activation in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Mesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Bone marrow-derived progenitor cells in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Mesenchymal stem cells in tumor development: emerging roles and concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Cell-based therapy for prevention and reversal of myocardial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Stem cells and pulmonary fibrosis: cause or cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1204PP

10.1164/RCCM.201207-1204PP

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference